No Data
Williams-Sonoma, Wix.com, Dolby Laboratories And Other Big Stocks Moving Higher On Wednesday
HUTCHMED Appoints Experienced Director to Board
Hutchmed (China) (00013.HK) appointed Hu Zhaohong as an independent non-executive director and a member of the technical committee.
Gelonghui, November 20 - Hutchmed (00013.HK) today announced that Hu Chaohong has been appointed as the company's independent non-executive director and member of the technical committee, effective from November 21, 2024. Dr. Hu has over 20 years of experience in therapeutic antibodies, antibody-drug conjugates, and vaccine development. Throughout her career, she has demonstrated strong leadership and innovation capabilities, leading multiple research and development programs. Dr. Hu's expertise spans from early discovery to clinical development and commercialization. She also has a good track record in successful business development and establishing strategic partnerships (including licensing and collaboration).
Bullish market stimulation boosts Hong Kong healthcare stocks, causing Lai Kai Pharmaceuticals to surge over 18%.
①What bullish news about pharmaceutical stocks has recently been announced in the market? ②How do institutions view the subsequent performance of pharmaceutical stocks?
Will the indications of GLP-1 drugs expand to the field of PCOS? The era of three targets is about to arrive? | Industry Observation
①At the GLP-1 Drug Seminar (Chengdu session), participants discussed the global trend of GLP-1 drug research and development. ②Participants mentioned that the indications for GLP-1 drugs in the future may expand to areas such as PCOS and stroke. ③Drugs targeting GLP, GCG, and GIP receptors are beginning to rise.
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
No Data
No Data
